ID: ALA57541

Max Phase: Preclinical

Molecular Formula: C21H28O4

Molecular Weight: 344.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(OC/C(C)=C/C=C/C(C)=C/C(=O)O)c(C(C)(C)C)c1

Standard InChI:  InChI=1S/C21H28O4/c1-15(12-20(22)23)8-7-9-16(2)14-25-19-11-10-17(24-6)13-18(19)21(3,4)5/h7-13H,14H2,1-6H3,(H,22,23)/b8-7+,15-12+,16-9+

Standard InChI Key:  QJNPOWDWTDGCKH-ZLLKFVMWSA-N

Associated Targets(Human)

Cellular retinoic acid-binding protein I 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoic acid receptor alpha 153 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 344.45Molecular Weight (Monoisotopic): 344.1988AlogP: 4.90#Rotatable Bonds: 7
Polar Surface Area: 55.76Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.45CX Basic pKa: CX LogP: 4.90CX LogD: 2.05
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.56Np Likeness Score: 0.64

References

1. Shealy YF, Riordan JM, Frye JL, Simpson-Herren L, Sani BP, Hill DL..  (2003)  Inhibition of papilloma formation by analogues of 7,8-dihydroretinoic acid.,  46  (10): [PMID:12723955] [10.1021/jm020324t]

Source